TETRACYCLINE

Tetracycline Adverse Events Reported to the FDA Over Time

How are Tetracycline adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Tetracycline, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Tetracycline is flagged as the suspect drug causing the adverse event.

Most Common Tetracycline Adverse Events Reported to the FDA

What are the most common Tetracycline adverse events reported to the FDA?

Drug Hypersensitivity	64 (4.87%)
Rash	23 (1.75%)
Tooth Discolouration	23 (1.75%)
Nausea	19 (1.44%)
Drug Ineffective	16 (1.22%)
Vomiting	13 (.99%)
Weight Decreased	12 (.91%)
Alopecia	11 (.84%)
Dyspnoea	11 (.84%)
Hypersensitivity	11 (.84%)
Asthenia	10 (.76%)
	Show More
Diarrhoea	10 (.76%)
Headache	10 (.76%)
Myalgia	10 (.76%)
Neuralgia	10 (.76%)
No Adverse Event	10 (.76%)
Vision Blurred	10 (.76%)
Abdominal Pain Upper	9 (.68%)
Depression	9 (.68%)
Dizziness	9 (.68%)
Fatigue	9 (.68%)
Suicidal Ideation	9 (.68%)
Back Pain	8 (.61%)
Decreased Appetite	8 (.61%)
Drug Interaction	8 (.61%)
Faeces Discoloured	8 (.61%)
Gastrointestinal Disorder	8 (.61%)
Abdominal Pain	7 (.53%)
Benign Intracranial Hypertension	7 (.53%)
Hallucination	7 (.53%)
Iridocyclitis	7 (.53%)
Malaise	7 (.53%)
Mood Swings	7 (.53%)
Papilloedema	7 (.53%)
Urticaria	7 (.53%)
Anxiety	6 (.46%)
Aspartate Aminotransferase Increase...	6 (.46%)
Blister	6 (.46%)
Candidiasis	6 (.46%)
Chest Discomfort	6 (.46%)
Feeling Abnormal	6 (.46%)
Hepatotoxicity	6 (.46%)
Intentional Overdose	6 (.46%)
Palpitations	6 (.46%)
Pruritus	6 (.46%)
Arthralgia	5 (.38%)
Cardiac Arrest	5 (.38%)
Clostridial Infection	5 (.38%)
Confusional State	5 (.38%)
Drug Exposure During Pregnancy	5 (.38%)
Dry Eye	5 (.38%)
Eye Irritation	5 (.38%)
Heart Rate Increased	5 (.38%)
Intervertebral Disc Protrusion	5 (.38%)
Ocular Hyperaemia	5 (.38%)
Osteoporosis	5 (.38%)
Pancreatitis	5 (.38%)
Paralysis	5 (.38%)
Pyrexia	5 (.38%)
Renal Failure Acute	5 (.38%)
Sepsis	5 (.38%)
Stevens-johnson Syndrome	5 (.38%)
Suicide Attempt	5 (.38%)
Tongue Discolouration	5 (.38%)
Abdominal Discomfort	4 (.3%)
Adrenocortical Insufficiency Acute	4 (.3%)
Agitation	4 (.3%)
Alanine Aminotransferase Increased	4 (.3%)
Angioedema	4 (.3%)
Arrhythmia	4 (.3%)
Blood Alkaline Phosphatase Increase...	4 (.3%)
Blood Bilirubin Increased	4 (.3%)
Blood Glucose Increased	4 (.3%)
Blood Pressure Increased	4 (.3%)
Cardio-respiratory Arrest	4 (.3%)
Chest Pain	4 (.3%)
Coagulopathy	4 (.3%)
Convulsion	4 (.3%)
Depressed Mood	4 (.3%)
Drug Abuse	4 (.3%)
Drug Toxicity	4 (.3%)
Dysphagia	4 (.3%)
Erosive Oesophagitis	4 (.3%)
Eye Disorder	4 (.3%)
Hepatic Enzyme Increased	4 (.3%)
Hepatitis	4 (.3%)
Impaired Healing	4 (.3%)
Leukopenia	4 (.3%)
Liver Function Test Abnormal	4 (.3%)
Neck Pain	4 (.3%)
Oedema Peripheral	4 (.3%)
Oral Candidiasis	4 (.3%)
Pancytopenia	4 (.3%)
Paraesthesia	4 (.3%)
Sinus Tachycardia	4 (.3%)
Skin Discolouration	4 (.3%)
Staphylococcal Infection	4 (.3%)
Subarachnoid Haemorrhage	4 (.3%)
Swelling	4 (.3%)
Throat Tightness	4 (.3%)
Treatment Noncompliance	4 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Tetracycline, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tetracycline is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Tetracycline

What are the most common Tetracycline adverse events reported to the FDA?

Epidermal And Dermal Conditions	85 (6.46%)
Allergic Conditions	80 (6.08%)
Gastrointestinal Signs	74 (5.63%)
Neurological	44 (3.35%)
Respiratory	37 (2.81%)
Therapeutic And Nontherapeutic Effe...	37 (2.81%)
Infections - Pathogen Unspecified	31 (2.36%)
Dental And Gingival Conditions	28 (2.13%)
Cardiac Arrhythmias	27 (2.05%)
Hepatobiliary	26 (1.98%)
Vision	23 (1.75%)
	Show More
Hepatic And Hepatobiliary	22 (1.67%)
Skin Appendage Conditions	22 (1.67%)
Bacterial Infectious	21 (1.6%)
Physical Examination Topics	20 (1.52%)
Gastrointestinal Motility And Defec...	19 (1.44%)
Ocular Infections, Irritations And ...	19 (1.44%)
Anxiety Disorders	18 (1.37%)
Muscle	18 (1.37%)
Suicidal And Self-injurious Behavio...	17 (1.29%)
Fungal Infectious	16 (1.22%)
Musculoskeletal And Connective Tiss...	16 (1.22%)
Appetite And General Nutritional	15 (1.14%)
Cardiac And Vascular Investigations	15 (1.14%)
Movement Disorders	15 (1.14%)
Depressed Mood Disorders	14 (1.06%)
Medication Errors	14 (1.06%)
Mood Disorders	14 (1.06%)
Eye	12 (.91%)
Headaches	12 (.91%)
Angiedema And Urticaria	11 (.84%)
Chemical Injury And Poisoning	11 (.84%)
Hematology Investigations	11 (.84%)
Increased Intracranial Pressure And...	11 (.84%)
Lifestyle Issues	11 (.84%)
Personality Disorders	11 (.84%)
Renal Disorders	11 (.84%)
Gastrointestinal Conditions	9 (.68%)
Injuries	9 (.68%)
Joint	9 (.68%)
Procedural And Device Related Injur...	9 (.68%)
Tongue Conditions	9 (.68%)
Cardiac Disorder Signs	8 (.61%)
Deliria	8 (.61%)
Disturbances In Thinking	8 (.61%)
Metabolic, Nutritional And Blood Ga...	8 (.61%)
Tissue	8 (.61%)
White Blood Cell	8 (.61%)
Anemias Nonhemolytic And Marrow Dep...	7 (.53%)
Body Temperature Conditions	7 (.53%)
Enzyme	7 (.53%)
Musculoskeletal And Connective Tiss...	7 (.53%)
Ocular Structural Change, Deposit A...	7 (.53%)
Psychiatric	7 (.53%)
Water, Electrolyte And Mineral	7 (.53%)
Acid-base	6 (.46%)
Electrolyte And Fluid Balance Condi...	6 (.46%)
Exocrine Pancreas Conditions	6 (.46%)
Urinary Tract Signs	6 (.46%)
Bone Disorders	5 (.38%)
Central Nervous System Vascular	5 (.38%)
Coagulopathies And Bleeding Diathes...	5 (.38%)
Gastrointestinal Ulceration And Per...	5 (.38%)
Peripheral Neuropathies	5 (.38%)
Platelet	5 (.38%)
Renal And Urinary Tract Investigati...	5 (.38%)
Administration Site Reactions	4 (.3%)
Adrenal Gland	4 (.3%)
Bone, Calcium, Magnesium And Phosph...	4 (.3%)
Bronchial Disorders	4 (.3%)
Manic And Bipolar Mood Disorders	4 (.3%)
Neonatal And Perinatal Conditions	4 (.3%)
Ocular Sensory Symptoms	4 (.3%)
Oral Soft Tissue Conditions	4 (.3%)
Protein And Chemistry Analyses	4 (.3%)
Seizures	4 (.3%)
Sleep Disorders	4 (.3%)
Upper Respiratory Tract Disorders	4 (.3%)
Encephalopathies	3 (.23%)
Hematological And Lymphoid Tissue T...	3 (.23%)
Immune	3 (.23%)
Maternal Complications Of Labour An...	3 (.23%)
Mental Impairment	3 (.23%)
Therapeutic Procedures And Supporti...	3 (.23%)
Toxicology And Therapeutic Drug Mon...	3 (.23%)
Ancillary Infectious Topics	2 (.15%)
Bladder And Bladder Neck Disorders	2 (.15%)
Cardiac And Vascular Disorders Cong...	2 (.15%)
Connective Tissue Disorders	2 (.15%)
Cutaneous Neoplasms Benign	2 (.15%)
Endocrine Investigations	2 (.15%)
Injuries By Physical Agents	2 (.15%)
Inner Ear And Viiith Cranial Nerve	2 (.15%)
Lipid Analyses	2 (.15%)
Lipid Metabolism	2 (.15%)
Microbiology And Serology	2 (.15%)
Nephropathies	2 (.15%)
Neurological Disorders Of The Eye	2 (.15%)
Ovarian And Fallopian Tube	2 (.15%)
Pigmentation	2 (.15%)
Retina, Choroid And Vitreous Hemorr...	2 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Tetracycline, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tetracycline is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.